In patients who are severely ill with COVID-19, the glycosylation of anti-spike IgG is changed, which can lead to pathology by over-activation of IgG effector functions, as we show here by particularly amplifying the production of COVID-19-associated cytokines such as IL-6 and TNF (5, 42). This evidence concerns the gene IL6 and COVID-19.